Investor insights
Sectors invested in
Life Science1
Biotechnology1
Pharmaceutical1
Funding rounds participated in
$194M sweet spot round size
Most of their 1 investments are in rounds between $194M and $194M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
Early Phase Clinical Research
Regulatory Affairs
Medical Writing
Phase II-III Clinical Research
Cell and gene therapy clinical development
Central Laboratories
Nephrology clinical development
Clinical Monitoring
Infectious Disease clinical development
Neuroscience clinical development
Metabolic and endocrine clinical development
Bioanalytical Laboratories
Clinical Trial Management
Drug Safety and Pharmacovigilance
Quality Assurance
Oncology clinical development
Biostatistics and Data Sciences
Rare disease clinical development
Imaging & ECG Core Labs
RWE-Late Phase Clinical Research
Medical Device and Diagnostics
Cardiovascular clinical development
Date founded
1992
Investments made
N
NewAmsterdam Pharma raised $194M on January 14, 2021
Investors: Forbion, GL Capital Group, Morningside Venture Capital 晨兴资本, JVC Investment Partners, Presight Capital, LSP (Life Sciences Partners) and Medpace